Personalized Medicine World Conference, May 2017 at Duke

[John Mac]

http://www.bioquicknews.com/node/4263

A very moving and informative session on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), was held in the mid-afternoon of Day 1 (May 24) at the Personalized Medicine World Conference (PMWC) 2017 at Duke.

The three speakers were Zaher Nahle, PhD, MPA, Chief Scientific Officer and Vice President for Research at the Solve ME/CFS Initiative (SMCI) (http://solvecfs.org/) research & advocacy organization;
Anthony L. Komaroff (photo), MD, Professor of Medicine, Harvard Medical School, and Senior Physician, Brigham and Women’s Hospital;
John Nicols, MBA, CEO of Codexis (http://www.codexis.com/), a protein-engineering company.

 

[Jesse2233]

it was mentioned that Metabolon is working with the SMCI to analyze metabolites in ME/CFS patients and that early analysis has demonstrated a lower-than-normal level of molybdenum in ME/CFS patients.

 

[trishrhymes]

Great news that ME is being highlighted at this conference. I hope it stimulates more researchers to work on ME.

 

[CFS_for_19_years]

The speakers were [.....] and John Nicols, MBA, CEO of Codexis (http://www.codexis.com/), a protein-engineering company. Mr. Nicols’ wife Marcy, who was in the audience, has had ME/CFS for 25 years.